This week, 3 Pharmaceuticals stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).
Zoetis, Inc. Class A (ZTS) improves from a C to a B rating this week. The company also gets A’s in operating margin growth, earnings momentum, and return on equity. For more information, get Portfolio Grader’s complete analysis of ZTS stock.
Amphastar Pharmaceuticals, Inc. (AMPH) shows solid improvement this week. The company’s rating rises from a C to a B. The company also gets A’s in earnings revisions. For more information, get Portfolio Grader’s complete analysis of AMPH stock.
This is a strong week for ProPhase Labs, Inc. (PRPH). The company’s rating climbs to B from the previous week’s C. ProPhase Labs, Inc. manufactures zinc gluconate glycine lozenges and homeopathic gum. For more information, get Portfolio Grader’s complete analysis of PRPH stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.